• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚微米颗粒对干扰素-β-1a 溶液长期储存过程中微米级颗粒形成的影响。

Effects of submicron particles on formation of micron-sized particles during long-term storage of an interferon-β-1a solution.

机构信息

Protein Pharmaceutical Development, Biogen Idec, Cambridge, Massachusetts 02142, USA.

出版信息

J Pharm Sci. 2013 Feb;102(2):347-51. doi: 10.1002/jps.23414. Epub 2012 Dec 11.

DOI:10.1002/jps.23414
PMID:23233283
Abstract

We present evidence that homogeneous submicron particles can influence the growth rate of larger particles upon long-term storage in a temperature-dependent manner. Interferon-beta-1a was thermally stressed at 50°C for 6 h and characterized using nanoparticle tracking analysis (NTA), microflow digital imaging (MFI), and circular dichroism (CD) spectroscopy. This study showed selective formation of submicron particles exhibiting a perturbed protein conformation. These thermally induced submicron particles were spiked into an unstressed solution at three levels, and then monitored for micron-sized particle formation upon storage at 5°C and 25°C for 12 months. The resulting particle growth effects were temperature dependent. NTA and MFI results at 5°C showed little evidence that initial submicron particle levels impacted particle growth across the range ~0.03-25 μm. In contrast, MFI results at 25°C indicated that particle growth in the 1-10 μm size range correlated strongly with initial submicron particle levels, and particle counts in the 10-25 μm size range were highest after 12 months for the samples with highest initial submicron particle content.

摘要

我们提供的证据表明,在温度依赖的方式下,均匀的亚微米颗粒可以影响大颗粒的生长速率。干扰素-β-1a 在 50°C 下热应激 6 小时,并使用纳米颗粒跟踪分析(NTA)、微流动数字成像(MFI)和圆二色性(CD)光谱进行表征。这项研究表明,亚微米颗粒的选择性形成表现出蛋白质构象的扰动。这些热诱导的亚微米颗粒被注入到未受应力的溶液中三个水平,然后在 5°C 和 25°C 下储存 12 个月,监测微米级颗粒的形成。由此产生的颗粒生长效应是温度依赖性的。在 5°C 时,NTA 和 MFI 的结果几乎没有证据表明初始亚微米颗粒水平会影响~0.03-25μm 范围内的颗粒生长。相比之下,在 25°C 时,MFI 的结果表明,1-10μm 大小范围内的颗粒生长与初始亚微米颗粒水平密切相关,并且在 12 个月后,初始亚微米颗粒含量最高的样品中 10-25μm 大小范围内的颗粒计数最高。

相似文献

1
Effects of submicron particles on formation of micron-sized particles during long-term storage of an interferon-β-1a solution.亚微米颗粒对干扰素-β-1a 溶液长期储存过程中微米级颗粒形成的影响。
J Pharm Sci. 2013 Feb;102(2):347-51. doi: 10.1002/jps.23414. Epub 2012 Dec 11.
2
Characterization of submicron (0.1-1 μm) particles in therapeutic proteins by nanoparticle tracking analysis.通过纳米颗粒跟踪分析对治疗性蛋白质中的亚微米(0.1 - 1μm)颗粒进行表征。
J Pharm Sci. 2015 May;104(5):1622-31. doi: 10.1002/jps.24411. Epub 2015 Mar 3.
3
The Impact of Inadequate Temperature Storage Conditions on Aggregate and Particle Formation in Drugs Containing Tumor Necrosis Factor-Alpha Inhibitors.温度储存条件不足对含肿瘤坏死因子-α抑制剂药物中聚集和颗粒形成的影响。
Pharm Res. 2018 Feb 5;35(2):42. doi: 10.1007/s11095-017-2341-x.
4
Interference from Proteins and Surfactants on Particle Size Distributions Measured by Nanoparticle Tracking Analysis (NTA).蛋白质和表面活性剂对纳米颗粒跟踪分析(NTA)测量的粒度分布的干扰。
Pharm Res. 2017 Apr;34(4):800-808. doi: 10.1007/s11095-017-2109-3. Epub 2017 Feb 2.
5
Characterization and quantitation of aggregates and particles in interferon-β products: potential links between product quality attributes and immunogenicity.干扰素-β产品中聚集体和颗粒的特性描述和定量:产品质量属性与免疫原性之间的潜在联系。
J Pharm Sci. 2013 Mar;102(3):915-28. doi: 10.1002/jps.23415. Epub 2012 Dec 11.
6
A Comprehensive Evaluation of Nanoparticle Tracking Analysis (NanoSight) for Characterization of Proteinaceous Submicron Particles.用于蛋白质亚微米颗粒表征的纳米颗粒跟踪分析(NanoSight)综合评估
J Pharm Sci. 2016 Nov;105(11):3366-3375. doi: 10.1016/j.xphs.2016.08.009. Epub 2016 Sep 24.
7
Evaluation of Incremental Siliconization Levels on Soluble Aggregates, Submicron and Subvisible Particles in a Prefilled Syringe Product.预充式注射器产品中增量硅化水平对可溶性聚集体、亚微米和亚可见颗粒的影响评估。
J Pharm Sci. 2016 Jan;105(1):50-63. doi: 10.1016/j.xphs.2015.10.012. Epub 2015 Dec 22.
8
Compatibility, physical stability, and characterization of an IgG4 monoclonal antibody after dilution into different intravenous administration bags.IgG4 单克隆抗体稀释至不同静脉输注袋后的相容性、物理稳定性和特性。
J Pharm Sci. 2012 Oct;101(10):3636-50. doi: 10.1002/jps.23224. Epub 2012 Jun 25.
9
Characterization of Nanoparticle Tracking Analysis for Quantification and Sizing of Submicron Particles of Therapeutic Proteins.用于定量和测定治疗性蛋白质亚微米颗粒的纳米颗粒跟踪分析的特性
J Pharm Sci. 2015 Aug;104(8):2441-50. doi: 10.1002/jps.24510. Epub 2015 May 27.
10
Practical Considerations for Detection and Characterization of Sub-Micron Particles in Protein Solutions by Nanoparticle Tracking Analysis.通过纳米颗粒跟踪分析检测和表征蛋白质溶液中亚微米颗粒的实际考虑因素
PDA J Pharm Sci Technol. 2015 May-Jun;69(3):427-39. doi: 10.5731/pdajpst.2015.01051.

引用本文的文献

1
Protein Nanoparticles Promote Microparticle Formation in Intravenous Immunoglobulin Solutions During Freeze-Thawing and Agitation Stresses.蛋白质纳米颗粒在静脉注射免疫球蛋白溶液的冻融和搅拌应激过程中促进微粒形成。
J Pharm Sci. 2018 Jul;107(7):1852-1857. doi: 10.1016/j.xphs.2018.03.016. Epub 2018 Mar 27.
2
Evaluation of Nanoparticle Tracking for Characterization of Fibrillar Protein Aggregates.用于表征纤维状蛋白质聚集体的纳米颗粒追踪评估
AIChE J. 2014 Apr 1;60(4):1236-1244. doi: 10.1002/aic.14349.